Tony Demarin
Shoppers Drug Mart Corp
SC-T
DON'T BUY
Sep 15, 2010
When Ontario government announced they were going to change the rules on generic drugs he took the opportunity to exit the stock and assess the landscape in the next couple of years. Expect other provincial governments will follow. Still good growth opportunities in Western Canada. Well managed, pays a dividend and trades at a reasonable multiple but he would like more clarity on the rules.
$61.29 is full value. Loblaw’s is fairly fully valued. There is too much competition, even if Target is struggling in Canada. Prefers THI-T but it is fully valued. Same with Canadian Tire or Sears. Dollarama would be a better entry point.
(A Top Pick May 16/13. Up 29.79%.) Sold his holdings in October because the transaction by Loblaw’s (L-T) involved quite a few shares being swapped and he did not want exposure to food retailing.
2.36% bond maturing May 24/18. A company that you don’t get many choices to buy in the consumer area. Credit quality is good at A minus and the yield spread is attractive.
(A Top Pick June 19/13. Up 27.54%.) Had not been expecting the takeout by Loblaws (L-T), but just bought this because it was a quality retailer generating a lot of free cash flow and paying down their debts.
(Top Pick May 16/13, Up 34.12%)He did not keep the Loblaw’s shares because he did not want to be exposed to food retailers. He is now sitting on the cash from this.
(A Top Pick Jan 29/14. Up 2.96%.) 2.36% bond maturing May 24/18. This has rolled down the curve with a positive return of over 3%. It will continue to generate positive returns.
(Past Top Pick June 6, 2014, Bond matures May 24,2018, up 3.79%) Had a good balance sheet, but folded into Loblaws now, Performed well. Most bonds yields have been going sideways since late 2014.